^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    depatuxizumab (ABT-806)

    i
    Other names: ABT-806, mAb-806, ch806, MAb806
    Associations
    News
    Trials
    Company:
    AbbVie, Life Science Pharma
    Drug class:
    EGFR inhibitor
    Related drugs:
    Associations
    News
    Trials